Does LORLATINIB Cause Peripheral sensory neuropathy? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Peripheral sensory neuropathy have been filed in association with LORLATINIB (Lorbrena). This represents 0.2% of all adverse event reports for LORLATINIB.
9
Reports of Peripheral sensory neuropathy with LORLATINIB
0.2%
of all LORLATINIB reports
3
Deaths
6
Hospitalizations
How Dangerous Is Peripheral sensory neuropathy From LORLATINIB?
Of the 9 reports, 3 (33.3%) resulted in death, 6 (66.7%) required hospitalization.
Is Peripheral sensory neuropathy Listed in the Official Label?
Yes, Peripheral sensory neuropathy is listed as a known adverse reaction in the official FDA drug label for LORLATINIB.
What Other Side Effects Does LORLATINIB Cause?
Death (1,050)
Neoplasm progression (633)
Off label use (394)
Weight increased (306)
Hallucination (290)
Blood cholesterol increased (281)
Dyspnoea (223)
Oedema peripheral (198)
Oedema (195)
Fatigue (188)
What Other Drugs Cause Peripheral sensory neuropathy?
PACLITAXEL (554)
OXALIPLATIN (510)
DEXAMETHASONE (435)
CYCLOPHOSPHAMIDE (407)
BEVACIZUMAB (382)
DOXORUBICIN (358)
FLUOROURACIL (345)
CARBOPLATIN (332)
VINCRISTINE (295)
BORTEZOMIB (290)
Which LORLATINIB Alternatives Have Lower Peripheral sensory neuropathy Risk?
LORLATINIB vs LORMETAZEPAM
LORLATINIB vs LORNOXICAM
LORLATINIB vs LOSARTAN
LORLATINIB vs LOSARTAN\LOSARTAN
LORLATINIB vs LOTEPREDNOL ETABONATE